{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:41:33Z","timestamp":1793727693427,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.nucmedbio.2023.108351","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T01:05:15Z","timestamp":1684199115000},"page":"108351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo"],"prefix":"10.1016","volume":"120-121","author":[{"given":"Christian W.","family":"Wichmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Poniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Roselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Van Zuylekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid J.G.","family":"Burvenich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morandeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifaza","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Hegi-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"MacManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nucmedbio.2023.108351_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2023.108351_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncol"},{"issue":"14","key":"10.1016\/j.nucmedbio.2023.108351_bb0015","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.nucmedbio.2023.108351_bb0020","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2023.108351_bb0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00259-020-05002-7","article-title":"Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET","volume":"48","author":"Chomet","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"80","key":"10.1016\/j.nucmedbio.2023.108351_bb0030","doi-asserted-by":"crossref","first-page":"11889","DOI":"10.1039\/C6CC05961A","article-title":"A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies","volume":"52","author":"Rudd","year":"2016","journal-title":"Chem Commun"},{"issue":"4","key":"10.1016\/j.nucmedbio.2023.108351_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nprot.2010.13","article-title":"Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine","volume":"5","author":"Vosjan","year":"2010","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.nucmedbio.2023.108351_bb0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00259-009-1263-1","article-title":"p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging","volume":"37","author":"Perk","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.nucmedbio.2023.108351_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008859","article-title":"Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2\/neu expression in mice using Zr-DFO-trastuzumab","volume":"5","author":"Holland","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nucmedbio.2023.108351_bb0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2967\/jnumed.121.261926","article-title":"First-in-human study of 89Zr-pembrolizumab PET\/CT in patients with advanced stage non-small-cell lung cancer","volume":"63","author":"Niemeijer","year":"2022","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2023.108351_bb0055","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s00259-021-05251-0","article-title":"Radiolabelling and preclinical characterization of (89)Zr-Df-radiolabelled bispecific anti-PD-L1\/TGF-\u03b2RII fusion protein bintrafusp alfa","volume":"48","author":"Burvenich","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.nucmedbio.2023.108351_bb0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/157340611796799186","article-title":"89Zr radiochemistry for positron emission tomography","volume":"7","author":"Severin","year":"2011","journal-title":"Med Chem"},{"issue":"5","key":"10.1016\/j.nucmedbio.2023.108351_bb0065","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2967\/jnumed.118.217158","article-title":"Fully automated 89Zr labeling and purification of antibodies","volume":"60","author":"Poot","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2023.108351_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.nucmedbio.2023.108351_bb0075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/acs.bioconjchem.0c00087","article-title":"A systematic evaluation of antibody modification and 89Zr-radiolabeling for optimized immuno-PET","volume":"32","author":"Sharma","year":"2021","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2023.108351_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccr.2017.05.011","article-title":"Copper, gallium and zirconium positron emission tomography imaging agents: the importance of metal ion speciation","volume":"352","author":"McInnes","year":"2017","journal-title":"Coord Chem Rev"},{"issue":"3","key":"10.1016\/j.nucmedbio.2023.108351_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2967\/jnumed.119.230961","article-title":"Total-body PET and highly stable chelators together enable meaningful 89Zr-antibody-PET studies up to 30 days post-injection","volume":"61","author":"Berg","year":"2020","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.nucmedbio.2023.108351_bb0090","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/molecules24081534","article-title":"Preparation of zirconium-89 solutions for radiopharmaceutical purposes: interrelation between formulation, radiochemical purity, stability and biodistribution","volume":"24","author":"Larenkov","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.nucmedbio.2023.108351_bb0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0883-2927(95)00026-7","article-title":"The aqueous geochemistry of Zr and the solubility of some Zr-bearing minerals","volume":"10","author":"Aja","year":"1995","journal-title":"Appl Geochem"},{"issue":"11","key":"10.1016\/j.nucmedbio.2023.108351_bb0100","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/(SICI)1099-0682(199811)1998:11<1765::AID-EJIC1765>3.0.CO;2-#","article-title":"Thermodynamic stability of Zirconium(IV) complexes with hydroxy ions","volume":"1998","author":"Veyland","year":"1998","journal-title":"Eur J Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2023.108351_bb0105","series-title":"The hydrolysis of cations","author":"Baes","year":"1976"},{"issue":"7","key":"10.1016\/j.nucmedbio.2023.108351_bb0110","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.nucmedbio.2009.05.007","article-title":"Standardized methods for the production of high specific-activity zirconium-89","volume":"36","author":"Holland","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2023.108351_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1389-1723(01)80127-4","article-title":"On the adsorption of proteins on solid surfaces, a common but very complicated phenomenon","volume":"91","author":"Nakanishi","year":"2001","journal-title":"J Biosci Bioeng"},{"issue":"1","key":"10.1016\/j.nucmedbio.2023.108351_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ab.2011.02.009","article-title":"The importance of using the optimal plasticware and glassware in studies involving peptides","volume":"414","author":"Goebel-Stengel","year":"2011","journal-title":"Anal Biochem"},{"issue":"2","key":"10.1016\/j.nucmedbio.2023.108351_bb0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jps.24265","article-title":"Competitive adsorption of monoclonal antibodies and nonionic surfactants at solid hydrophobic surfaces","volume":"104","author":"Kapp","year":"2015","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.nucmedbio.2023.108351_bb0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/19420862.2015.1046664","article-title":"Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration","volume":"7","author":"Morar-Mitrica","year":"2015","journal-title":"mAbs"},{"issue":"12","key":"10.1016\/j.nucmedbio.2023.108351_bb0135","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2967\/jnumed.118.224568","article-title":"89Zr-immuno-PET: toward a noninvasive clinical tool to measure target engagement of therapeutic antibodies in vivo","volume":"60","author":"Jauw","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805123000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805123000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:31:18Z","timestamp":1760848278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805123000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":27,"alternative-id":["S0969805123000380"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108351","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108351"}}